BioCentury
ARTICLE | Strategy

Biotech kibbutz

January 16, 2014 8:00 AM UTC

Johnson & Johnson and Takeda Pharmaceutical Co. Ltd. have established a beachhead in Israel by partnering with the government and OrbiMed Advisors LLC to build FutuRx Ltd., a collectively owned biotech incubator. The incubator is part of a global portfolio of partnerships and investments by Johnson & Johnson Innovation, the pharma's early stage collaborations unit.

FutuRx is the result of efforts by Israel's Office of the Chief Scientist (OCS) to commercialize technology that originates in universities by linking Israeli academics and startups with global pharmas...